Epsilogen
PrivateLast Round
Series B
Extension
Sep 9, 2024
Total Funding Raised
$72.51M
Company Overview
Epsilogen is a biopharmaceutical company focused on developing immunoglobulin antibodies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epsilogen Comps
Public and private peers based on sector, stage, and business model.
Epsilogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 9, 2024 | ||||
| Series B | Mar 2, 2022 | ||||
| Grant | Oct 21, 2020 | ||||
| Grant | Jul 20, 2020 | ||||
| Series A Extension | Apr 20, 2020 | ||||
Grant | Apr 2, 2019 |
Key People
Founding team and executive leadership
Epsilogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| UK government | Grant |
| Epidarex Capital | Series B, Series A, Series A Extension, Series B Extension |
| ALSA Ventures | Series B Extension, Series B |
| British Patient Capital | Series B Extension, Series B |
| ALSA Holdings | Series B Extension, Series A, Series A Extension, Series B |
| Schroders Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
Cristina Oliva appointed as Chief Medical Officer.
- Apr 9, 2025
Dr. Sonia Gulati appointed to the Board of Directors.
Epsilogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epsilogen's valuation, stock price, and market status.
